SCHEMBL2491636

SCHEMBL2491636

c1ccc(C(c2ccccc2)(c2ccncc2)N2CCCCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.52
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
KCNH2 Q12809 5/20 0.40
KCNA5 P22460 3/20 0.40
CHKA P35790 1/20 0.39
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
CHRM2 P08172 3/20 0.38
CHRM1 P11229 3/20 0.38
HTR1A P08908 2/20 0.38
CYP2D6 P10635 2/20 0.38
OPRM1 P35372 2/20 0.38
KIF11 P52732 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP19A1 P11511 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19296941 0.88 CYP2B6 (0.63) CYP2B6KCNH2KCNA5LMNACHRM2
SCHEMBL2491599 0.88 CYP2B6 (0.63) CYP2B6KCNH2KCNA5LMNACHRM2
SCHEMBL2392136 0.86 CYP2B6 (0.59) CYP2B6CYP11B1CYP11B2KCNH2KCNA5
SCHEMBL27753492 0.82 CYP2B6 (0.54) CYP2B6CYP11B1CYP11B2KCNH2KCNA5
SCHEMBL12199488 0.78 CYP2B6 (0.56) CYP2B6KCNH2LMNACHRM2CHRM1
SCHEMBL27544718 0.78 ESR1 (0.52) CYP2B6KCNH2LMNAMAPTCHRM2
SCHEMBL2489520 0.78 CYP2B6 (0.56) CYP2B6KCNH2LMNACHRM2CHRM1
SCHEMBL9650536 0.77 CYP2B6 (0.46) CYP2B6CYP11B1CYP11B2KCNH2KCNA5
SCHEMBL2495637 0.76 ESR1 (0.53) CYP2B6KCNH2LMNAMAPTCHRM2
SCHEMBL2490819 0.74 CYP2B6 (0.51) CYP2B6KCNH2LMNAMAPTCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH CYP2B6 105/4885CYP11B1 20/4885CYP11B2 25/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 CYP2B6 100/4885CYP11B1 19/4885CYP11B2 22/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R CYP2B6 110/4885CYP11B1 17/4885CYP11B2 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.